Rab39tm1b(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Rab39tm1b(KOMP)Wtsi |
Name: |
RAB39, member RAS oncogene family; targeted mutation 1b, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:5505641 |
Gene: |
Rab39 Location: Chr9:53595410-53617532 bp, - strand Genetic Position: Chr9, 29.12 cM
|
Alliance: |
Rab39tm1b(KOMP)Wtsi page
|
IMPC: |
Rab39 gene page |
|
Mutant Cell Line: |
EPD0528_2_A11 |
Germline Transmission: |
Earliest citation of germline transmission:
J:188991
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 53595239 of Chromosome 9 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site was followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted downstream of the targeted exon(s) at position 53598425. The critical exon(s) were thus flanked by loxP sites and subsequent cre expression excised the critical sequence yielding a reporter knockout allele. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:148605, J:173534, J:188991)
|
|
|
|
|
Original: |
J:188991 The Jackson Laboratory, Alleles produced for the KOMP project by The Jackson Laboratory. MGI Direct Data Submission. 2012; |
All: |
6 reference(s) |
|